Ariel E. Feldstein

34.6k total citations · 15 hit papers
220 papers, 26.9k citations indexed

About

Ariel E. Feldstein is a scholar working on Epidemiology, Hepatology and Endocrinology, Diabetes and Metabolism. According to data from OpenAlex, Ariel E. Feldstein has authored 220 papers receiving a total of 26.9k indexed citations (citations by other indexed papers that have themselves been cited), including 171 papers in Epidemiology, 82 papers in Hepatology and 57 papers in Endocrinology, Diabetes and Metabolism. Recurrent topics in Ariel E. Feldstein's work include Liver Disease Diagnosis and Treatment (161 papers), Diet, Metabolism, and Disease (51 papers) and Liver Disease and Transplantation (44 papers). Ariel E. Feldstein is often cited by papers focused on Liver Disease Diagnosis and Treatment (161 papers), Diet, Metabolism, and Disease (51 papers) and Liver Disease and Transplantation (44 papers). Ariel E. Feldstein collaborates with scholars based in United States, Germany and Italy. Ariel E. Feldstein's co-authors include Paul Angulo, Rocío López, Ali Canbay, Naim Alkhouri, Keith D. Lindor, Alexander Wree, Leon A. Adams, Akiko Eguchi, Anna Więckowska and Nizar N. Zein and has published in prestigious journals such as Nature, Journal of Biological Chemistry and Journal of Clinical Investigation.

In The Last Decade

Ariel E. Feldstein

215 papers receiving 26.5k citations

Hit Papers

5 papers align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Gut flora metabolism of phosphatidylcholine promotes cardiovascular disease

2011 4.1k citations Ariel E. Feldstein, Philip R. Schauer et al. profile →
The Natural History of Nonalcoholic Fatty Liver Disease: A Population-Based Cohort Study

2005 2.2k citations Ariel E. Feldstein et al. profile →
NLRP3 inflammasome blockade reduces liver inflammation and fibrosis in experimental NASH in mice

2017 863 citations Alexander Wree, Casey D. Johnson et al. Journal of Hepatology profile →
Hepatocyte apoptosis and fas expression are prominent features of human nonalcoholic steatohepatitis

2003 860 citations Ariel E. Feldstein et al. profile →
NLRP3 inflammasome activation results in hepatocyte pyroptosis, liver inflammation, and fibrosis in mice

2013 779 citations Alexander Wree, Akiko Eguchi et al. profile →
Triggering and resolution of inflammation in NASH

2018 681 citations Ariel E. Feldstein et al. profile →
Free fatty acids promote hepatic lipotoxicity by stimulating TNF-α expression via a lysosomal pathway

2004 655 citations Ariel E. Feldstein et al. profile →
The natural history of non-alcoholic fatty liver disease in children: a follow-up study for up to 20 years

2009 550 citations Ariel E. Feldstein et al. Gut profile →
Cytokeratin-18 Fragment Levels as Noninvasive Biomarkers for Nonalcoholic Steatohepatitis

2009 520 citations Ariel E. Feldstein, Rocío López et al. profile →
In vivo assessment of liver cell apoptosis as a novel biomarker of disease severity in nonalcoholic fatty liver disease

2006 509 citations Nizar N. Zein, Lisa Yerian et al. profile →
From NAFLD to NASH to cirrhosis—new insights into disease mechanisms

2013 491 citations Alexander Wree, Lori Broderick et al. profile →
Increased Hepatic and Circulating Interleukin-6 Levels in Human Nonalcoholic Steatohepatitis

2008 481 citations Rocío López, Nizar N. Zein et al. The American Journal of Gastroenterology profile →
NLRP3 inflammasome activation is required for fibrosis development in NAFLD

2014 404 citations Alexander Wree, Hal M. Hoffman et al. profile →
Innate Immunity and Inflammation in NAFLD/NASH

2016 392 citations Ariel E. Feldstein et al. profile →
Dynamic Shifts in the Composition of Resident and Recruited Macrophages Influence Tissue Remodeling in NASH

2021 245 citations Sabine Daemen, Anastasiia Gainullina et al. Cell Reports profile →

Peers

Countries citing papers authored by Ariel E. Feldstein

Since Specialization

Citations

This map shows the geographic impact of Ariel E. Feldstein's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ariel E. Feldstein with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ariel E. Feldstein more than expected).

Fields of papers citing papers by Ariel E. Feldstein

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ariel E. Feldstein. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ariel E. Feldstein. The network helps show where Ariel E. Feldstein may publish in the future.

Co-authorship network of co-authors of Ariel E. Feldstein

This figure shows the co-authorship network connecting the top 25 collaborators of Ariel E. Feldstein. A scholar is included among the top collaborators of Ariel E. Feldstein based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ariel E. Feldstein. Ariel E. Feldstein is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Antisense Oligonucleotide Therapy Decreases IL-1β Expression and Prolongs Survival in Mutant Nlrp3 Mice 2023 ·The Journal of Immunology ·Benedikt Kaufmann, (unknown), Laela M. Booshehri, Janset Onyuru, Aleksandra Leszczynska, (unknown), Sven Michel, Richard Klar, Frank Jaschinski, Ariel E. Feldstein, Lori Broderick, Hal M. Hoffman	6
2	BRP39 Regulates Neutrophil Recruitment in NLRP3 Inflammasome-Induced Liver Inflammation 2023 ·Cellular and Molecular Gastroenterology and Hepatology ·(unknown), (unknown), Janset Onyuru, Hal M. Hoffman, Ariel E. Feldstein	15
3	Dynamic Shifts in the Composition of Resident and Recruited Macrophages Influence Tissue Remodeling in NASH breakdown → 2021 ·Cell Reports ·Sabine Daemen, Anastasiia Gainullina, Gowri Kalugotla, Li He, Mandy M. Chan, Joseph W. Beals, Kim Liss, Samuel Klein, Ariel E. Feldstein, Brian N. Finck, Maxim N. Artyomov, Joel D. Schilling	245
4	A Low ω-6 to ω-3 PUFA Ratio (n–6:n–3 PUFA) Diet to Treat Fatty Liver Disease in Obese Youth 2020 ·Journal of Nutrition ·Michelle Van Name, Mary Savoye, (unknown), (unknown), Ariel E. Feldstein, Bridget Pierpont, Casey D. Johnson, Veronika Shabanova, Udeme D. Ekong, Pamela L. Valentino, Grace Kim, Sonia Caprio, Nicola Santoro	57
5	Extracellular vesicles, the liquid biopsy of the future 2019 ·Journal of Hepatology ·Akiko Eguchi, Enis Kostallari, Ariel E. Feldstein, Vijay H. Shah	53
6	Differential Activation of Hepatic Invariant NKT Cell Subsets Plays a Key Role in Progression of Nonalcoholic Steatohepatitis 2018 ·The Journal of Immunology ·Igor Maricic, Idania Marrero, Akiko Eguchi, Ryota Nakamura, Casey D. Johnson, Suryasarathi Dasgupta, Carolyn Hernandez, Phirum Nguyen, Austin D. Swafford, Rob Knight, Ariel E. Feldstein, Rohit Loomba, Vipin Kumar	78
7	Liquid biopsy for liver diseases 2018 ·Gut ·Jelena Mann, Helen L. Reeves, Ariel E. Feldstein	77
8	Microvesicles released from fat-laden cells promote activation of hepatocellular NLRP3 inflammasome: A pro-inflammatory link between lipotoxicity and non-alcoholic steatohepatitis 2017 ·PLoS ONE ·Stefania Cannito, Elisabetta Morello, Claudia Bocca, Beatrice Foglia, Elisa Benetti, Erica Novo, Fausto Chiazza, Mara Rogazzo, Roberto Fantozzi, Davide Povero, Salvatore Sutti, Elisabetta Bugianesi, Ariel E. Feldstein, Emanuele Albano, Massimo Collino, Maurizio Parola	55
9	Hepatic Stellate Cell Specific NLRP3 Inflammasome Activation Results in Spontaneous Fibrosis 2016 ·RWTH Publications (RWTH Aachen) ·Casey D. Johnson, Alexander Wree, (unknown), Davide Povero, Akiko Eguchi, Robert F. Schwabe, Hal M. Hoffman, Ariel E. Feldstein	1
10	Microparticles Release by Adipocytes Act as “Find-Me” Signals to Promote Macrophage Migration 2015 ·PLoS ONE ·Akiko Eguchi, Anny Mulya, Miloš Lazić, (unknown), Michael Berk, Davide Povero, Agnieszka Górnicka, Ariel E. Feldstein	93
11	Insulin Resistance Increases MRI-Estimated Pancreatic Fat in Nonalcoholic Fatty Liver Disease and Normal Controls 2013 ·Gastroenterology Research and Practice ·N. Patel, Michael R. Peterson, Grace Lin, Ariel E. Feldstein, Bernd Schnabl, Ricki Bettencourt, Ekihiro Seki, Claude B. Sirlin, Rohit Loomba	48
12	1271 REDUCED DIETARY OMEGA-6:OMEGA-3 RATIO AND 12/15-LIPOXYGENASE DEFICIENCY PROTECT FROM HIGH FAT DIET-INDUCED STEATOHEPATITIS 2013 ·Journal of Hepatology ·Miloš Lazić, (unknown), Davide Povero, (unknown), (unknown), (unknown), Yury I. Miller, Alejandra C. Cherñavsky, Ariel E. Feldstein, Dorothy D. Sears	1
13	Oxidized Fatty Acids: A Potential Pathogenic Link Between Fatty Liver and Type 2 Diabetes in Obese Adolescents? 2013 ·Antioxidants and Redox Signaling ·Nicola Santoro, Sonia Caprio, Cosimo Giannini, Grace Kim, Romy Kursawe, Bridget Pierpont, Melissa Shaw, Ariel E. Feldstein	36
14	Inhibition of Apoptosis Protects Mice from Ethanol‐Mediated Acceleration of Early Markers of CC l ₄ ‐Induced Fibrosis but not Steatosis or Inflammation 2012 ·Alcoholism Clinical and Experimental Research ·Sanjoy Roychowdhury, Dian Chiang, Palash Mandal, Megan R. McMullen, Xiuli Liu, Jessica I. Cohen, John R. Pollard, Ariel E. Feldstein, Laura E. Nagy	64
15	Mass spectrometric profiling of oxidized lipid products in human nonalcoholic fatty liver disease and nonalcoholic steatohepatitis 2010 ·Journal of Lipid Research ·Ariel E. Feldstein, Rocío López, (unknown), Lisa Yerian, Yoon-Mi Chung, Michael Berk, Renliang Zhang, Thomas M. McIntyre, Stanley L. Hazen	230
16	Novel Insights into the Pathophysiology of Nonalcoholic Fatty Liver Disease 2010 ·Seminars in Liver Disease ·Ariel E. Feldstein	101
17	Adipocyte Apoptosis, a Link between Obesity, Insulin Resistance, and Hepatic Steatosis 2009 ·Journal of Biological Chemistry ·Naim Alkhouri, Agnieszka Górnicka, Michael Berk, Samjhana Thapaliya, Laura J. Dixon, Sangeeta R. Kashyap, Philip R. Schauer, Ariel E. Feldstein	307
18	Cytokines in the Pathogenesis of Fatty Liver and Disease Progression to Steatohepatitis: Implications for Treatment 2008 ·The American Journal of Gastroenterology ·Christine Carter‐Kent, Nizar N. Zein, Ariel E. Feldstein	167
19	New methods to investigate the intrarenal distribution of blood flow and tubular fluid flow dynamics 1999 ·Current Opinion in Nephrology & Hypertension ·J. Carlos Romero, (unknown), Ariel E. Feldstein, Lilach O. Lerman	2
20	Prevention of Work-Related Disability 1998 ·American Journal of Preventive Medicine ·Ariel E. Feldstein	9

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact